Terug
Dagbereik
€ 3,87
€ 4,00
52-Weeksbereik
€ 1,05
€ 4,98
Volume
305.762
50D / 200D Gem.
€ 3,98
/
€ 3,66
Vorige Slotkoers
€ 4,05
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,5 | 0,3 |
| P/B | — | 3,0 |
| ROE % | — | 3,7 |
| Net Margin % | -175,3 | 3,8 |
| Rev Growth 5Y % | 24,5 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 7,50
+90.4%
Low: € 5,00
High: € 10,00
Forward WPA
-€ 0,81
Omzet Sch.
79,67M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,82
€ 0,72 – € 0,89
|
458,28M | 2 |
| FY2029 |
€ 0,60
€ 0,54 – € 0,66
|
405,98M | 2 |
| FY2028 |
€ 0,04
-€ 0,65 – € 0,62
|
278,48M | 4 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 24,45% annually over 5 years — strong growth
Negative free cash flow of -141,44M
PEG of 0,10 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 9,60%
Capital efficient — spends only 0,32% of revenue on capex
Groei
Revenue Growth (5Y)
24,45%
Revenue (1Y)14,85%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-32,11%
Net Margin-175,31%
Op. Margin-133,21%
Veiligheid
Debt / Equity
N/A
Current Ratio4,37
Interest Coverage-2,10
Waardering
P/E Ratio
-3,51
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14,85% | Revenue Growth (3Y) | 8,15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 24,45% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 81,36M | Net Income (TTM) | -142,62M |
| ROE | N/A | ROA | -44,14% |
| Gross Margin | 90,57% | Operating Margin | -133,21% |
| Net Margin | -175,31% | Free Cash Flow (TTM) | -141,44M |
| ROIC | -32,11% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4,37 |
| Interest Coverage | -2,10 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3,51 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 6,15 |
| PEG Ratio | 0,10 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -28,26% | ||
| Market Cap | 500,55M | Enterprise Value | 678,23M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 81,36M | 70,84M | 69,56M | 209,91M | 33,92M |
| Net Income | -142,62M | -157,85M | -240,05M | -157,13M | -230,03M |
| EPS (Diluted) | -1,12 | -1,62 | -2,94 | -1,99 | -3,00 |
| Gross Profit | 73,68M | 64,89M | 67,03M | 206,61M | 32,52M |
| Operating Income | -108,38M | -130,65M | -165,99M | -123,34M | -261,72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 323,15M | 321,98M | 354,78M | 490,86M | 617,97M |
| Total Liabilities | 508,98M | 524,62M | 503,03M | 411,41M | 451,88M |
| Shareholders' Equity | -185,83M | -202,64M | -148,25M | 79,45M | 166,09M |
| Total Debt | 439,01M | 123,00M | 124,38M | 129,85M | 139,70M |
| Cash & Equivalents | 261,34M | 250,87M | 278,60M | 326,44M | 466,54M |
| Current Assets | 306,34M | 307,39M | 336,29M | 434,98M | 525,18M |
| Current Liabilities | 70,16M | 80,47M | 67,67M | 81,94M | 73,94M |